Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 0.559% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CCc1ccccc1NC(=O)/C(=C/c1ccco1)c1ccccc1
b. Cc1cccc(N2CC(C(=O)Nc3nnc(SCCN4CCOCC4)s3)CC2=O)c1
Answer: b. Cc1cccc(N2CC(C(=O)Nc3nnc(SCCN4CCOCC4)s3)CC2=O)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccc(N2CC(C(=O)Nc3nnc(SCCN4CCOCC4)s3)CC2=O)c1
Cc1cccc(N2CC(C(=O)Nc3nnc(SCCN4CCOCC4)s3)CC2=O)c1
1-(3-methylphenyl)-N-[5-(2-morpholin-4-ylethylsulfanyl)-1,3,4-thiadiazol-2-yl]-5-oxopyrrolidine-3-carboxamide